Sign Out
The most frequent events are headache, dizziness, peripheral oedema, palpitations and flushing.
Tabulated List of Adverse Reactions: Adverse reactions listed as follows have been observed during clinical studies and/or during marketed use and are based on clinical trial data and classified according to MedDRA System Organ Class. Frequency categories are defined according to the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000) and not known (cannot be estimated from the available data.). (See table.)
Click on icon to see table/diagram/image
View ADR Reporting Link
Continue with Google